Clinical Trial Update: Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia [Phase 2]

View source ↗

Summary

Phase 2 trial investigates cardiac effects of mineralocorticoid receptor antagonism after preeclampsia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypertension | Phase 2 | Status: RECRUITING